IBI-Ag
Rony Oren Benaroya's work experience includes founding and serving as the Chief Technology Officer at IBI-Ag Ltd. since August 2017. Prior to that, they worked as the VP of Synthetic Biology at SynVaccine Ltd. from October 2013 to July 2017. Rony also worked as the Director of Research and Preclinical Development at Bio-Vent Ltd. from March 2007 to October 2012.
Rony Oren Benaroya completed a PhD degree at The Hebrew University of Jerusalem from 1997 to 2002. Following this, from 2003 to 2008, Rony pursued a postdoctoral position at the Weizmann Institute of Science. No specific field of study was provided for either degree.
This person is not in any teams
This person is not in any offices
IBI-Ag
IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.